A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism

Abstract

HIV can use an alternative mechanism to become resistant to PI by changing the substrate instead of the protease. Further studies are required to determine to what extent cleavage site mutations may explain virological failure during PI therapy.